Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana M Sobieraj

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Development and implementation of a program to assess medical patients' need for venous thromboembolism prophylaxisDiana M Sobieraj
Pharmacotherapy|April 30, 2013
The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgeryMandana Mahmoudi, Diana M Sobieraj
Thrombosis Research|April 10, 2014
Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolismNayon Kang, Diana M Sobieraj
International Journal of Cardiology|July 11, 2015
The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolismLindsay Hom, Diana M Sobieraj
The Annals of Pharmacotherapy|June 3, 2010
Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitusDiana M Sobieraj, Craig W Freyer
JAMA|September 8, 2018
SMART in the Management of Patients With Persistent Asthma-ReplyDiana M Sobieraj, William L Baker
The Annals of Pharmacotherapy|August 12, 2021
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary DiseaseStefanie C Nigro, Diana M Sobieraj
Connecticut Medicine|March 31, 2016
Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug InteractionsEva Y Pan, Diana M Sobieraj
Journal of the American Pharmacists Association : Japha|November 18, 2023
Response to editorial about systematic review of self-reported adherence toolsNathaniel M Rickles, Diana M Sobieraj
Connecticut Medicine|August 12, 2016
The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery DeviceEmily A Perriello, Diana M Sobieraj
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Development and implementation of a program to assess medical patients' need for venous thromboembolism prophylaxisDiana M Sobieraj
Pharmacotherapy|April 30, 2013
The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgeryMandana Mahmoudi, Diana M Sobieraj
Thrombosis Research|April 10, 2014
Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolismNayon Kang, Diana M Sobieraj
International Journal of Cardiology|July 11, 2015
The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolismLindsay Hom, Diana M Sobieraj
The Annals of Pharmacotherapy|June 3, 2010
Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitusDiana M Sobieraj, Craig W Freyer
JAMA|September 8, 2018
SMART in the Management of Patients With Persistent Asthma-ReplyDiana M Sobieraj, William L Baker
The Annals of Pharmacotherapy|August 12, 2021
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary DiseaseStefanie C Nigro, Diana M Sobieraj
Connecticut Medicine|March 31, 2016
Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug InteractionsEva Y Pan, Diana M Sobieraj
Journal of the American Pharmacists Association : Japha|November 18, 2023
Response to editorial about systematic review of self-reported adherence toolsNathaniel M Rickles, Diana M Sobieraj
Connecticut Medicine|August 12, 2016
The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery DeviceEmily A Perriello, Diana M Sobieraj
Pageof 8